Search
for
Sort by
Research 361–390 of 1000+
- 4-O-Methylhonokiol: A lesser-known neolignan from Magnolia species with diverse and promising pharmacological properties
- Androgen Receptor Ligands: Agonists and Antagonists
- Evaluation of serum brain-derived neurotrophic factor to assess the association between psoriasis and depression
- Melanocytes and Vitiligo (and Hair Graying)
- Cosmeceuticals in Dermatology
- Cytokine-targeted treatment in alopecia areata - new possibilities?
- Actinic Keratosis: Risk Factors, Clinical, Diagnosis and Therapeutics Aspects. Part I
- Erosive Pustular Dermatosis of the Scalp Due to Afatinib: A Rare Case
- Adrenal causes of endocrine hypertension in childhood or adolescence
- Turning JAK STATic, a peek into the future of dermatology therapeutics
- Development of MALDI-TOF-MS and MALDI-MSI methods for hair analysis and evaluation of cosmetic treatments
- Small Molecule Inhibitors and Inflammatory Skin Diseases
- Medications
- Cytostatics and immunosuppressive drugs
- Prevalence of the Polycystic Ovary Syndrome in Unselected Black and White Women of the Southeastern United States: A Prospective Study<sup>1</sup>
- Prevalence of the Polycystic Ovary Syndrome in Unselected Black and White Women of the Southeastern United States: A Prospective Study
- Relative Prevalence of Different Androgen Excess Disorders in 950 Women Referred because of Clinical Hyperandrogenism
- The cutaneous serotoninergic/melatoninergic system: securing a place under the sun
- Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review
- <i>Hoxc13</i> mutant mice lack external hair
- Oral retinoids-present status
- Platelet-Rich Plasma for Androgenetic Alopecia
- Maternal PPARγ protects nursing neonates by suppressing the production of inflammatory milk
- Ovarian Hypertension: Polycystic Ovary Syndrome
- Idiopathic Hirsutism*
- Bone density is normal in male rats treated with finasteride.
- MicroRNA in skin diseases
- Antiandrogen Treatment with Spironolactone and Linestrenol Decreases Bone Mineral Density in Eumenorrhoeic Women with Androgen Excess
- Clinical markers of androgenicity in acne vulgaris
- First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: A phase II study